Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma.

× No keyword cloud information.

7 in total

1. Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy.

Authors: Arjun Gupta; Samar Harris; Steven Vernino; Harris V Naina
Journal: Clin Auton Res Date: 2015-08-07 Impact factor: 4.435

2. Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients.

Authors: Nicolò Compagno; Francesco Cinetto; Gianpietro Semenzato; Carlo Agostini
Journal: Haematologica Date: 2014-03-28 Impact factor: 9.941

Review 3. B cell-targeted therapy for rheumatoid arthritis: an update on the evidence.

Authors: R John Looney
Journal: Drugs Date: 2006 Impact factor: 9.546

4. Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis.

Authors: Erika Irie; Yuko Shirota; Chihiro Suzuki; Yumi Tajima; Kenichi Ishizawa; Junichi Kameoka; Hideo Harigae; Tomonori Ishii
Journal: Int J Hematol Date: 2010-03-10 Impact factor: 2.490

5. Persistence of Virus-Specific Antibody after Depletion of Memory B Cells.

Authors: William A Langley; Andreas Wieland; Hasan Ahmed; Mohammed Ata Ur Rasheed; Carl W Davis; Jaturong Sewatanon; Scott N Mueller; Mark J Shlomchik; Veronika I Zarnitsyna; Rustom Antia; Rafi Ahmed
Journal: J Virol Date: 2022-04-11 Impact factor: 6.549

Review 6. Immunoglobulin replacement therapy in secondary hypogammaglobulinemia.

Authors: Nicolò Compagno; Giacomo Malipiero; Francesco Cinetto; Carlo Agostini
Journal: Front Immunol Date: 2014-12-08 Impact factor: 7.561

7. Reactivation of Occult Hepatitis B Virus Infection 27 Months after the End of Chemotherapy Including Rituximab for Malignant Lymphoma.

Authors: Junichi Muraishi; Michihiko Shibata; Yuichi Honma; Masaaki Hiura; Shintaro Abe; Masaru Harada
Journal: Intern Med Date: 2017-08-01 Impact factor: 1.271

7 in total